Bioprosthetic Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA) during transcatheter aortic valve-in-valve implantation with bioprosthetic valve fracturing via the transcaval access

Jonas Lanz1, MD, MSc; Thomas Pilgrim1, MD; Adam B. Greenbaum2, MD; Stephan Windecker1*, MD

1. Department of Cardiology, Swiss Cardiovascular Center, University Hospital Bern, Bern, Switzerland; 2. Center for Structural Heart Disease, Division of Cardiology, Henry Ford Hospital, Detroit, MI, USA

S. Windecker has received research grants to the institution from Abbott, Amgen, Biotronik, Boston Scientific, St. Jude Medical, Terumo and Bayer. T. Pilgrim has received research grants to the institution from Biotronik, Sym

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Interventions for valvular diseaseTAVI

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Early commercial experience from transcatheter aortic valve implantation using the Portico™ bioprosthetic valve: 30-day outcomes in the multicentre PORTICO-1 study